Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma

European Urology Supplements - Tập 7 - Trang 593-600 - 2008
Jan Roigas1
1Department of Urology, Vivantes Klinikum Am Urban, Dieffenbachstrasse 1, D-10967 Berlin, Berlin, Germany

Tài liệu tham khảo

Houk, 2007, A population pharmacokinetic/pharmacodynamic (PK/PD) analysis of exposure-response for sunitinib in metastatic renal cell carcinoma (mRCC) [abstract], Eur J Cancer Suppl, 5, 299, 10.1016/S1359-6349(07)71136-9

Sutent, summary of product characteristics. New York, NY: Pfizer Inc; 2008.

Motzer, 2006, Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma, J Clin Oncol, 24, 16, 10.1200/JCO.2005.02.2574

Motzer, 2006, Sunitinib in patients with metastatic renal cell carcinoma, JAMA, 295, 2516, 10.1001/jama.295.21.2516

Motzer, 2007, Sunitinib efficacy against advanced renal cell carcinoma, J Urol, 178, 1883, 10.1016/j.juro.2007.07.030

Motzer, 2007, Sunitinib versus interferon alfa in metastatic renal-cell carcinoma, N Engl J Med, 356, 115, 10.1056/NEJMoa065044

Gore, 2007, Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis [abstract], Eur J Cancer Suppl, 5, 299, 10.1016/S1359-6349(07)71134-5

Bellmunt, 2008, Sunitinib in advanced renal cell carcinoma: clinical evidence, Eur Urol Suppl, 7, 585, 10.1016/j.eursup.2008.07.010

Negrier, 2007, Optimisation of sunitinib therapy in metastatic renal cell carcinoma: adverse-event management, Eur J Cancer Suppl, 5, 12, 10.1016/S1359-6349(07)70110-6

Robert, 2005, Cutaneous side-effects of kinase inhibitors and blocking antibodies, Lancet Oncol, 6, 491, 10.1016/S1470-2045(05)70243-6

Rini, 2007, Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib, J Natl Cancer Inst, 99, 81, 10.1093/jnci/djk008

Schöffski, 2006, Sunitinib-related thyroid dysfunction: a single-center retrospective and prospective evaluation, J Clin Oncol, 24, 3092, 10.1200/jco.2006.24.18_suppl.3092

Raut, 2007, Postoperative experience in patients with metastatic GIST are similar in patients while on sunitinib or imatinib, Eur J Cancer Suppl, 5, 409, 10.1016/S1359-6349(07)71499-4

Thibault, 2008, Perioperative use and surgical complications of sunitinib in metastatic renal cell carcinoma, Eur Urol Suppl, 7, 306, 10.1016/S1569-9056(08)60938-0

Thông tin
Thông tin xuất bản

European Urology Supplements

Tập 7

593-600

Thông tin tác giả